TEBALDI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 2.593
AS - Asia 604
EU - Europa 541
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.742
Nazione #
US - Stati Uniti d'America 2.586
CN - Cina 261
SG - Singapore 176
IT - Italia 153
UA - Ucraina 82
TR - Turchia 79
DE - Germania 75
GB - Regno Unito 69
SE - Svezia 55
ID - Indonesia 47
FR - Francia 37
FI - Finlandia 32
PL - Polonia 24
HK - Hong Kong 12
VN - Vietnam 9
BE - Belgio 7
CA - Canada 7
IN - India 5
IR - Iran 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
CH - Svizzera 2
MY - Malesia 2
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
JP - Giappone 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
PH - Filippine 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 3.742
Città #
Fairfield 387
Woodbridge 310
Ashburn 271
Houston 181
Chandler 173
Singapore 140
Seattle 132
Wilmington 127
Cambridge 122
Jacksonville 110
Ann Arbor 105
Princeton 61
Beijing 58
Izmir 51
Jakarta 47
San Diego 47
New York 45
Shanghai 42
Nanjing 40
Ferrara 38
Milan 30
Warsaw 24
Bremen 19
Boardman 17
Los Angeles 16
Santa Clara 16
London 15
Nanchang 13
Bologna 11
Falls Church 11
Chicago 10
Hong Kong 10
Dong Ket 9
Augusta 8
Jiaxing 8
Lappeenranta 8
Shenyang 8
Tianjin 8
Brussels 7
Hebei 7
Norwalk 7
Washington 7
Helsinki 6
Mountain View 6
Toronto 6
Changsha 5
Ningbo 5
Addison 4
Auburn Hills 4
Des Moines 4
Indiana 4
Kunming 4
Redmond 4
Redwood City 4
Duncan 3
Frankfurt am Main 3
Guangzhou 3
Hounslow 3
Munich 3
Orange 3
San Mateo 3
Ahmedabad 2
Arezzo 2
Ascoli Satriano 2
Bari 2
Bondeno 2
Chengdu 2
Dubai 2
Florence 2
Kansas City 2
Kilburn 2
Kuala Lumpur 2
Lugo 2
Mumbai 2
Osogna 2
Parma 2
Romainville 2
Rome 2
Schio 2
Southwark 2
São Paulo 2
Taizhou 2
Tehran 2
Vazzola 2
Acton 1
Alfonsine 1
Ardabil 1
Baotou 1
Brno 1
Buffalo 1
Capannori 1
Cattolica 1
Chisinau 1
Chiswick 1
Colombo 1
Cona 1
Council Bluffs 1
Dearborn 1
Dhaka 1
Easton 1
Totale 2.895
Nome #
Poor response to clopidogrel: current and future options for its management 144
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 141
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 135
Fractional flow reserve: Current applications and overview of the available data 132
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 128
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 126
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 123
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 117
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 115
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 111
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 109
Fractional flow reserve implementation in daily clinical practice: A European survey 108
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 106
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 105
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 104
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) 100
null 94
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 93
Angina and left ventricular dysfunction: can we "reduce' it? 90
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 82
Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients? 81
Seven french radial artery access for PCI: A prospective single-center experience 79
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 75
Enhanced stent visualization systems during PCI: A case series and review of literature 73
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 69
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 68
Functional Assessment and Acute Coronary Syndrome 68
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 64
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 63
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 63
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 61
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 61
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 60
Coronary Microvascular Dysfunction: PET, CMR and CT Assessment 60
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. 58
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 55
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 53
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 43
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 41
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 39
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 38
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 38
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 36
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 31
Comment on [Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease] 25
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 24
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 23
Quantitative flow ratio as a new tool for angiography-based physiological evaluation of coronary artery disease: a review 23
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 22
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial 22
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 21
Low FFR equal to low ischemia: Really? 17
Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine 15
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial 13
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review 13
Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study 12
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 11
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 9
The unbearable lightness of the instantaneous wave-free ratio/fractional flow reserve discordance 7
Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study 3
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction 3
Totale 3.903
Categoria #
all - tutte 26.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.945


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020485 0 0 0 0 57 94 70 71 73 65 39 16
2020/2021553 28 29 28 59 16 33 25 80 31 90 87 47
2021/2022624 86 57 52 28 21 34 34 43 16 40 66 147
2022/2023471 59 23 36 27 74 62 25 49 66 6 32 12
2023/2024439 24 34 18 15 30 85 23 80 6 15 8 101
2024/2025333 25 36 130 82 60 0 0 0 0 0 0 0
Totale 3.903